Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
JAMA Psychiatry
|
July 2, 2025
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial
Adam Janik, Xin Qiu, Rosanne Lane, et al.
Innovations in Clinical Neuroscience
|
February 21, 2012
Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scale
Michael H Allen, David G Daniel, Dennis A Revicki, et al.
Innovations in Clinical Neuroscience
|
August 12, 2022
SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties
Larry Alphs, Dong-Jing Fu, David Williamson, et al.
Journal of Affective Disorders
|
January 13, 2023
Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A)
Jonathan Rabinowitz, Janet B W Williams, Nanco Hefting, et al.
Clinical Chemistry
|
May 19, 2007
Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transport
Thomas M Daly, Carmen M Dumaual, Xin Miao, et al.
Innovations in Clinical Neuroscience
|
April 6, 2022
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials
Erica A Smith, William P Horan, Dominique Demolle, et al.
The International Journal of Neuropsychopharmacology
|
May 4, 2025
Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study
Naim Zaki, Li Nancy Chen, Rosanne Lane, et al.
The American Journal of Psychiatry
|
October 1, 2025
Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Carla M Canuso, Cynthia Bossie, Dong-Jing Fu, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 5, 2026
Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study"
Andreas Reif, A Elif Anıl Yağcıoğlu, Istvan Bitter, et al.
The New England Journal of Medicine
|
October 4, 2023
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
Andreas Reif, Istvan Bitter, Jozefien Buyze, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
JAMA Psychiatry
|
July 2, 2025
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial
Adam Janik, Xin Qiu, Rosanne Lane, et al.
Innovations in Clinical Neuroscience
|
February 21, 2012
Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scale
Michael H Allen, David G Daniel, Dennis A Revicki, et al.
Innovations in Clinical Neuroscience
|
August 12, 2022
SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties
Larry Alphs, Dong-Jing Fu, David Williamson, et al.
Journal of Affective Disorders
|
January 13, 2023
Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A)
Jonathan Rabinowitz, Janet B W Williams, Nanco Hefting, et al.
Clinical Chemistry
|
May 19, 2007
Multiplex assay for comprehensive genotyping of genes involved in drug metabolism, excretion, and transport
Thomas M Daly, Carmen M Dumaual, Xin Miao, et al.
Innovations in Clinical Neuroscience
|
April 6, 2022
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials
Erica A Smith, William P Horan, Dominique Demolle, et al.
The International Journal of Neuropsychopharmacology
|
May 4, 2025
Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study
Naim Zaki, Li Nancy Chen, Rosanne Lane, et al.
The American Journal of Psychiatry
|
October 1, 2025
Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Carla M Canuso, Cynthia Bossie, Dong-Jing Fu, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 5, 2026
Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study"
Andreas Reif, A Elif Anıl Yağcıoğlu, Istvan Bitter, et al.
The New England Journal of Medicine
|
October 4, 2023
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
Andreas Reif, Istvan Bitter, Jozefien Buyze, et al.
Page
of 8